Trading Window closed for Q2 FY27 results declaration

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹118.00

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%—

Other Textile Products peers, median of 191sector-1.2%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-1.3—-0.8—

Next day

—-1.3—-1.2—

—+0.0—-0.6—

-1.5-0.2-1.3-0.5-1.1

-0.8-3.0+2.1-2.0+1.2

—-2.7—-2.2—

+0.1-1.7+1.8-1.1+1.3

15d

-1.7-8.9+7.2-6.8+5.1

—————

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 191Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

SKYBIOTECH HEALTHCARE has closed its trading window from October 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended September 30, 2026. This is a standard compliance requirement under SEBI insider trading regulations. All designated persons and their immediate relatives are barred from trading in the companys shares during this period. The board meeting date to approve the results will be announced separately.

Likely market impact

Routine compliance filing; no direct impact on shareholders. Signals upcoming Q2 results announcement.